Cannara Biotech Inc.
LOVFF
$1.34
-$0.02-1.47%
OTC PK
05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
---|---|---|---|---|---|
Net Income | 11.14M | 9.68M | 4.80M | 4.66M | 3.94M |
Total Depreciation and Amortization | 4.46M | 4.67M | 4.61M | 4.67M | 4.37M |
Total Amortization of Deferred Charges | 67.50K | 67.50K | 39.10K | 14.90K | 193.30K |
Total Other Non-Cash Items | 344.70K | -2.17M | 676.70K | 340.50K | 2.27M |
Change in Net Operating Assets | -1.34M | -4.29M | 1.67M | -1.56M | -2.79M |
Cash from Operations | 14.67M | 7.96M | 11.80M | 8.13M | 7.97M |
Capital Expenditure | -3.84M | -4.53M | -4.34M | -5.49M | -6.46M |
Sale of Property, Plant, and Equipment | 21.90K | 1.55M | 1.55M | 1.55M | 1.63M |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 151.40K | 141.10K | 123.70K | 120.70K | 122.50K |
Cash from Investing | -3.67M | -2.84M | -2.67M | -3.81M | -4.71M |
Total Debt Issued | 500.00K | 2.70M | 3.70M | 5.70M | 7.20M |
Total Debt Repaid | -3.00M | -4.35M | -4.74M | -4.67M | -4.61M |
Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
Repurchase of Common Stock | 0.00 | 0.00 | -4.30K | -277.10K | -480.50K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -3.79M | -3.28M | -3.81M | -4.28M | -5.06M |
Cash from Financing | -4.50M | -3.55M | -3.57M | -2.59M | -2.20M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | 0.00 |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 6.50M | 1.57M | 5.57M | 1.73M | 1.07M |